REG - BATM Advanced Comm - ADOR appoints Nadhim Zahawi to lead Advisory Board

Batm Advanced CommunicationsAnnouncement

16/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250116:nRSP5046Ta&default-theme=true

RNS Number : 5046T  BATM Advanced Communications Ld  16 January 2025

LEI: 213800FLQUB9J289RU66

16 January 2025

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

ADOR Diagnostics appoints Nadhim Zahawi to lead its Advisory Board

Former Chancellor of the Exchequer and Vaccine Deployment Minister of the
British Government and established global businessman to provide strategic
guidance and advice as ADOR progresses towards commercialisation

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for
networking solutions and medical laboratory systems, is delighted to announce
that ADOR Diagnostics ("ADOR"), an associate company of the Group, has
appointed the Rt. Hon Nadhim Zahawi as Chairman of its Advisory Board. Mr.
Zahawi, who brings a wealth of experience in government and business, will
provide strategic guidance and advice to support ADOR as it enters the next
phase of its growth strategy to commercialise its extensive R&D and
transform healthcare through cutting-edge diagnostic solutions.

 

Mr. Zahawi began his career in business before co-founding YouGov in 2000,
which became one of the world's largest polling and market research companies,
having listed on the London Stock Exchange in 2005, and now employs over 400
people across three continents. In 2010, he became a Member of Parliament and
held several roles in the British Government, including serving as Chancellor
of the Exchequer, Secretary of State for Education and as Minister for
COVID-19 Vaccine Deployment.

 

ADOR's NATlab molecular biology platform is currently undergoing pre-clinical
validation at the Lazzaro Spallanzani National Institute for Infectious
Diseases in Rome, Italy, a leading centre for infectious disease research and
treatment. Successful completion of the pre-clinical validation is expected to
enable initial sales of the NATlab and the commencement of the regulatory
process under the European Union In Vitro Diagnostic Medical Device Regulation
to become eligible for sale in the EU market.

 

Moti Nagar, Chief Executive Officer of BATM, said: "We are thrilled that
Nadhim Zahawi has joined the Advisory Board at ADOR. His wealth of experience
and success across both private enterprise and government, including from his
time working on the UK's COVID vaccine rollout, will be invaluable as ADOR
progresses to the next stage in its journey to commercialise its disruptive
diagnostic solutions that aim to transform how disease is detected and
managed. This is a very exciting moment for ADOR and we look to the future
with great confidence."

 

Rt. Hon Nadhim Zahawi commented: "I am delighted to join ADOR to chair its
Advisory Board. The potential for health tech to change the world is only just
starting to be grasped. For individuals and for families, ADOR Diagnostics
provides a concrete opportunity for a healthier, better life and a release
from suffering and concern. For whole nations struggling under ever-increasing
healthcare budgets, they will provide amazing tools to help transform
treatment. I saw the impact great healthcare innovations have through the
COVID pandemic, and am excited to help ADOR take the fight to disease and ill
health and change face of diagnosis."

 

 

Enquiries

 

 BATM
 Moti Nagar, Chief Executive Officer                            +972 9866 2525
 Ran Noy, Chief Financial Officer

 Shore Capital
 Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)  +44 20 7408 4050

 Gracechurch Group
 Harry Chathli, Claire Norbury                                  +44 20 4582 3500

 

 

Forward-looking statements

 

This document contains forward-looking statements. Those statements reflect
the current opinions, evaluations and estimations of the Group's management,
and are based on the current data regarding the Group's business as is
detailed in this document and in the Group's periodical, interim and immediate
reports. The Group does not undertake any obligation or make any
representation that actual results and events will be in line with those
statements, and stresses that they may differ materially from those
statements, due to changes in the Group's business, market, competition,
demand for the Group's products or services, general economic factors or other
factors that can influence the Group's business and results, due to the risk
factors that are detailed in the Group's Annual Report, and due to information
and factors that are currently unknown to the Group's management and that, if
known, would affect the management's opinions, evaluations or estimations. The
Group will report the actual results and events according to its legal,
accounting and regulatory obligations, and does not undertake any other
obligation to report them or their deviations from the forward-looking
statements, or to update any of the forward-looking statements in this
document or to report that it is not valid anymore.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNGPUPWGUPAGRA